Target intelligence / Profile preview

Calcium homeostasis modulator protein 5 (CALHM5)

Target
CALHM5
Molecular classification
Ion channel, ATP release channel, Other (part of the CALHM protein family)
01

Overview

Calcium homeostasis modulator protein 5 (CALHM5) is a large pore channel protein that assembles as an undecamer in the plasma membrane with four transmembrane helices and an unusually large hydrophobic pore stabilized by tightly bound membrane lipids[1][2][3][4]. It is predicted to participate in monoatomic cation transmembrane transport and ATP export[5]. CALHM5 shares key structural features with other CALHM family members but displays unique pore architecture and gating mechanisms involving lipid interactions. While its precise physiological role remains under study, dysfunction in related CALHM channels is implicated in neuronal pathology and neurodegenerative diseases such as Alzheimer’s disease[4]. The identification of its channel structure offers foundational insight for future functional studies and potential therapeutic targeting. No specific drugs or small molecules targeting CALHM5 are currently known.

Other names
CALHM5C6orf188FAM26EdJ493F7.3MGC45451family with sequence similarity 26 member Eprotein FAM26E
02

Mechanism of action

Lipid-mediated gating (lipid binding within the channel pore stabilizes and regulates open/closed states) Putative modulation of ATP and ion transport (largely inferred from CALHM family properties)

03

Biological functions

ATP exportMonoatomic cation transmembrane transportPutative regulation of neuronal excitabilityPutative involvement in taste signalingChannel assembly/gating regulated by membrane lipids
04

Disease associations

Neurodegenerative diseaseOther (general neurological function/pathology remains under investigation)
05

Safety considerations

None explicitly described; as role in human physiology is still being clarified, potential off-target channel activation or disruption of ATP export would be theoretical concerns if therapeutically targeted.

Beyond the preview

Go deeper on Calcium homeostasis modulator protein 5 (CALHM5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium homeostasis modulator protein 5 (CALHM5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call